These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3271157)

  • 1. [Relationship between gingival hyperplasia and transfer of phenytoin to saliva and serum].
    Bostanci H; Aksoy N; Timlioğlu O
    Ankara Univ Hekim Fak Derg; 1988 May; 15(2):193-6. PubMed ID: 3271157
    [No Abstract]   [Full Text] [Related]  

  • 2. [Application of drug monitoring with saliva--the influence of phenytoin upon the salivary inorganic constituents].
    Watanabe S; Igarashi S; Ichida T
    Rinsho Byori; 1986 Mar; 34(3):254-61. PubMed ID: 3712786
    [No Abstract]   [Full Text] [Related]  

  • 3. Gingival hyperplasia and diphenylhydantoin.
    Ciancio SG; Yaffe SJ; Catz CC
    J Periodontol; 1972 Jul; 43(7):411-4. PubMed ID: 4504524
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of phenytoin associated gingival enlargement--a 15-month longitudinal study.
    Pihlstrom BL; Carlson JF; Smith QT; Bastien SA; Keenan KM
    J Periodontol; 1980 Jun; 51(6):311-7. PubMed ID: 6930469
    [No Abstract]   [Full Text] [Related]  

  • 5. Levels of 5,5-diphenylhydantoin and its major metabolite in human serum, saliva, and hyperplastic gingiva.
    Conard GJ; Jeffay H; Boshes L; Steinberg AD
    J Dent Res; 1974; 53(6):1323-9. PubMed ID: 4529919
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gingival hyperplasia and diphenylhydantoin].
    Barone GP; Arata E; Salmeri S; Patrone M
    Parodontol Stomatol (Nuova); 1984; 23(3 Suppl 3):149-55. PubMed ID: 6443491
    [No Abstract]   [Full Text] [Related]  

  • 7. Diphenylhydantoin gingival hyperplasia in Macaca arctoides: a new human model.
    Staple PH; Reed MJ; Mashimo PA
    J Periodontol; 1977 Jun; 48(6):325-36. PubMed ID: 405470
    [No Abstract]   [Full Text] [Related]  

  • 8. [Confirmation of a workable relationship between saliva and plasma phenytoin concentrations in man as measured by radioimmunoassay].
    Alric R; Blayac JP; Negre C; Baldy-Moulinier M; Passouant P
    Therapie; 1978; 33(3):333-9. PubMed ID: 684685
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of phenytoin determinations in plasma, plasma dialysate and saliva for control of antiepileptic therapy in children.
    Brügmann G; Kleinau E; Nolte R; Petruch F
    Klin Wochenschr; 1979 Jan; 57(2):93-4. PubMed ID: 762949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saliva monitoring of anticonvulsants.
    Reynolds F; Knott C
    J Clin Chem Clin Biochem; 1989 Apr; 27(4):226-7. PubMed ID: 2738523
    [No Abstract]   [Full Text] [Related]  

  • 11. Parotid and whole saliva in the prediction of serum total and free phenytoin concentrations.
    Anavekar SN; Saunders RH; Wardell WM; Shoulson I; Emmings FG; Cook CE; Gringeri AJ
    Clin Pharmacol Ther; 1978 Dec; 24(6):629-37. PubMed ID: 710022
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of plasma and saliva levels of carbamazepine and phenytoin as monotherapy.
    Callaghan N; Goggin T
    Ir J Med Sci; 1984 May; 153(5):170-3. PubMed ID: 6480316
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current trends in periodontology. Hypertrophic-hyperplastic gingivopathy due to diphenylhydantoin].
    Weinstein R
    Mondo Odontostomatol; 1986; 28(2):81-6. PubMed ID: 3462493
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-induced gingival overgrowth.
    Jaiarj N
    J Mass Dent Soc; 2003; 52(3):16-20. PubMed ID: 14705579
    [No Abstract]   [Full Text] [Related]  

  • 15. On the relation of nitric oxide to nifedipine-induced gingival hyperplasia and impaired submandibular glands function in rats in vivo.
    Rezaie S; Rezaie A; Minaiee B; Khorasani R; Abdollahi M
    Fundam Clin Pharmacol; 2005 Feb; 19(1):65-71. PubMed ID: 15660961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GINGIVAL HYPERPLASIA AND DILANTIN CONTENT OF SALIVA: A PILOT STUDY.
    BABCOCK JR; NELSON GH
    J Am Dent Assoc; 1964 Feb; 68():195-8. PubMed ID: 14125030
    [No Abstract]   [Full Text] [Related]  

  • 17. [Salivary secretion and gingival hyperplasia in diphenyl hydantoin-treated guinea pigs].
    Westphal P
    Sven Tandlak Tidskr; 1969 Aug; 62(8):505-8. PubMed ID: 5267695
    [No Abstract]   [Full Text] [Related]  

  • 18. Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrations.
    Paxton JW; Rowell F; Ratcliffe JG; Lambie DG; Nanda R; Melville ID; Johnson RH
    Eur J Clin Pharmacol; 1977; 11(1):71-4. PubMed ID: 832662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphenylhydantoin concentrations in saliva.
    Bochner F; Hooper WD; Sutherland JM; Eadie MJ; Tyrer JH
    Arch Neurol; 1974 Jul; 31(1):57-9. PubMed ID: 4834542
    [No Abstract]   [Full Text] [Related]  

  • 20. The measured effect of phenytoin withdrawal on gingival hyperplasia in children.
    Brunsvold M; Tomasovic J; Ruemping D
    ASDC J Dent Child; 1985; 52(6):417-21. PubMed ID: 3864798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.